Pharmacy Times September 11, 2024
Gwen Nichols discusses challenges associated with the limited access to CAR T therapy and the need to expand outpatient and community care for patients.
In an interview with Pharmacy Times® at the Community Oncology Alliance (COA) 2024 Payer Exchange, Gwen Nichols, MD, executive vice president and chief medical officer of the Leukemia & Lymphoma Society (LLS), highlights the significant financial burden of cancer care, emphasizing how the high costs often prevent patients from accessing necessary treatments.
Pharmacy Times: What factors regarding treatment affordability were most significant in your session?
Gwen Nichols, MD: My role in the session was to talk about how cellular therapies, in particular, CAR T affordability, impacts patients’ access to the treatments. As we’re seeing really groundbreaking...
Today's Sponsors
Today's Sponsor